Measures of longitudinal adherence to fecal-based colorectal cancer screening: Literature review and recommended approaches
- PMID: 33811643
- DOI: 10.1002/ijc.33589
Measures of longitudinal adherence to fecal-based colorectal cancer screening: Literature review and recommended approaches
Abstract
The success of fecal occult blood-based colorectal cancer screening programs is dependent on repeating screening at short intervals (ie, every 1-2 years). We conducted a literature review to assess measures that have been used to assess longitudinal adherence to fecal-based screening. Among 46 citations identified and included in this review, six broad classifications of longitudinal adherence were identified: (a) stratified single-round attendance, (b) all possible adherence permutations, (c) consistent/inconsistent/never attendance, (d) number of times attended, (e) program adherence and (f) proportion of time covered. Advantages and disadvantages of these measures are described, and recommendations on which measures to use based on data availability and scientific question are also given. Stratified single round attendance is particularly useful for describing the yield of screening, while programmatic adherence measures are best suited to evaluating screening efficacy. We recommend that screening programs collect detailed longitudinal, individual-level data, not only for the screening tests themselves but additionally for diagnostic follow-up and surveillance exams, to allow for maximum flexibility in reporting adherence patterns using the measure of choice.
Keywords: colorectal cancer; fecal immunochemical testing; fecal occult blood testing; longitudinal adherence; screening.
© 2021 UICC.
References
REFERENCES
-
- IARC. Colorectal cancer screening. IARC Handb Cancer Prev. 2019;17:1-300. http://publications.iarc.fr/573.
-
- Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2016;315:2564-2575.
-
- Knudsen AB, Zauber AG, Rutter CM, et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US preventive services task force. JAMA. 2016;315:2595-2609.
-
- Zapka J, Taplin SH, Price RA, Cranos C, Yabroff R. Factors in quality care-the case of follow-up to abnormal cancer screening tests-problems in the steps and interfaces of care. J Natl Cancer Inst Monogr. 2010;2010:58-71.
-
- Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575-582.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
